Ginkgo Bioworks DNA Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ginkgo Bioworks's other working capital?
- Ginkgo Bioworks (DNA) reported other working capital of -$185K in Q1 2026.
- How has Ginkgo Bioworks's other working capital changed year-over-year?
- Ginkgo Bioworks's other working capital decreased by 24.2% year-over-year, from -$149K to -$185K.
- What is the long-term trend for Ginkgo Bioworks's other working capital?
- Over 2 years (2021 to 2025), Ginkgo Bioworks's other working capital has grown at a 870.7% compound annual growth rate (CAGR), from -$23K to -$2.17M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.